Awards Nomination
20+ Million Readerbase
PMC/PubMed Indexed Articles
Indexed In
- Open J Gate
- Academic Keys
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
- Geneva Foundation for Medical Education and Research
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Post- COVID mRNA vaccine myocarditis in children: Report of two cases
Joint Webinar: 8th World Summit on Neonatal Nursing and Pediatrics Healthcare & 9th International Conference on Mental Health and Psychiatry
May 22, 2023 | Webinar
Shamekh A*, Powell C, Ashabani A and Abdelgadir I
Sidra Medicine, Qatar
Posters & Accepted Abstracts: Health Care Curr Re
Abstract:
The SARS-COV-2 pandemic led to the development of several vaccinations to contain the disease. The Pfizer- BioNTech COVID-19(BNT162b2) vaccine was recommended on May 2021 for the use in children above 12 years and older. The vaccine is safe, well tolerated and highly effective. Initial reports showed no serious adverse events; however, cases of myocarditis in young healthy male adolescents were reported. We report two cases of myocarditis/perimyocarditis who presented with a short history of chest pain following administration of the second dose of the MRN COVID-19 vaccine.